Common and specific effects of the two major forms of prolactin in the rat testis

American Journal of Physiology - Endocrinology and Metabolism

Volumn 293, Issue 6, 2007, Pages

  Williams, Valencia L ^a   DeGuzman, Ariel ^a   Dang, Hong ^a   Kawaminami, Mitsumori ^b   Ho, Timothy W C ^a   Carter, David G ^c   Walker, Ameae M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KITASATO UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3 hydroxysteroid dehydrogenase; Apoptosis; Leydig cells; Luteinizing hormone; Luteinizing hormone receptor; Phosphorylated prolactin; S179D prolactin; Short prolactin receptor; Steroidogenic acute regulatory protein; Testosterone

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; LUTEINIZING HORMONE RECEPTOR; PROLACTIN; STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; LEYDIG CELL; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPERMATOGONIUM; TESTIS FUNCTION; TESTOSTERONE BLOOD LEVEL;

3-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LEYDIG CELLS; LUTEINIZING HORMONE; MALE; PHOSPHOPROTEINS; PHOSPHORYLATION; PITUITARY GLAND; PROLACTIN; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PUBERTY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LH; RECEPTORS, PROLACTIN; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TESTIS; TESTOSTERONE;

EID: 37149007438     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00541.2007     Document Type: Article

References (54)

1. Bartke A. Prolactin in the male: 25 years later. J Androl 25: 661-666, 2004.
2. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19: 225-268, 1998.
3. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25: 169-193, 2000.
4. Chen TJ, Kuo CB, Tsai KF, Liu JW, Chen DY, Walker AM. Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone. Endocrinology 139: 609-616, 1998.
5. Cheung CY. Prolactin suppresses luteinizing hormone secretion, and pituitary responsiveness to luteinizing hormone-releasing hormone by a direct action at the anterior pituitary. Endocrinology 113: 632-638, 1983.
6. Chomzynski P, Mackey K. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques 19: 942-945, 1995.
7. Coss D, Kuo CY, Yang L, Ingleton P, Luben R, Walker AM Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin. Endocrinology 140: 5087-5094, 1999.
8. Coss D, Yang L, Kuo CB, Xu X, Luben RA, Walker AM. Effects of prolactin on osteoblast alkaline phosphatase, and bone formation in the developing rat. Am J Physiol Endocrinol Metab 279: E1216-E1225, 2000.
9. Desjardins C. Endocrine signaling, and male reproduction. Biol Reprod 24: 1-2, 1981.
10. Dombrowicz D, Sente B, Closset J, Hennen G. Dose-dependent effects of human prolactin on the immature hypophysectomized rat testis. Endocrinology 130: 695-700, 1992.
11. Dufau ML. The luteinizing hormone receptor. Annu Rev Physiol 60: 461-490, 1998.
12. Francavilla S, D'Abrizio P, Rucci N, Silvano G, Properzi G, Straface E, Cordeschi G, Necozione S, Gnessi L, Arizzi M, Ulisse S. Fas and Fas ligand expression in fetal and adult human testis with normal or deranged spermatogenesis. J Clin Endocrinol Metab 85: 2692-2700, 2000.
13. Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 80: 1523-1631, 2000.
14. Gao HB, Tong MH, Hu YQ, You HY, Guo QS, Ge R, Hardy MP. Glucocorticoid induces apoptosis in rat Leydig cells. Endocrinology 143: 130-138, 2002.
15. Gao HB, Tong MH, Hu YQ, You HY, Guo QS, Ge R, Hardy MP. Mechanisms of glucocorticoid-induced Leydig cell apoptosis. Mol Cell Endocrinol 199: 153-163, 2003.
16. Garcia A, Herbon L, Barkan A, Papavasiliou S, Marshall JC. Hyperprolactinemia inhibits gonadotropin-releasing hormone (GnRH) stimulation of the number of pituitary GnRH receptors. Endocrinology 117: 954-959, 1985.
17. Greenan JR, Balden E, Ho TWC, Walker AM. Biosynthesis of the secreted 24 kd isoforms of prolactin. Endocrinology 125: 2041-2048, 1989.
18. Gregory SJ, Townsend J, McNeilly AS, Tortonese DJ. Effects of prolactin on the luteinizing hormone response to gonadotropin-releasing hormone in primary pituitary cell cultures during the ovine annual reproductive cycle. Biol Reprod 70: 1299-1305, 2004.
19. Hair WM, Gubbay O, Jabbour HN, Lincoln GA. Prolactin receptor expression in human testis, and accessory tissues: localization and function. Mol Human Reprod 3: 606-611, 2002.
20. Ho TWC, Kawaminami M, Walker AM. Secretion of phosphorylated, and nonphosphorylated monomer prolactin isoforms during rat pregnancy and pseudopregnancy. Endocrine 1: 435-439, 1993.
21. Ho TWC, Leong FS, Olaso CH, Walker AM. Secretion of specific nonphosphorylated, and phosphorylated rat prolactin isoforms at different stages of the estrous cycle. Neuroendocrinology 58: 160-165, 1993.
22. Hondo E, Kurohmaru M, Sakai S, Ogawa K, Hayashi Y. Prolactin receptor expression in rat spermatogenic cells. Biol Reprod 52: 1284-1290, 1995.
23. Huang WJ, Yeh JY, Tsai SC, Chiao YC, Chen JJ, Lu CC, Hwang SW, Wang SW, Chang LS, Wang PS. Regulation of testosterone secretion by prolactin in male rats. J Cell Biochem 74: 111-118, 1999.
24. Huang WJ, Yeh JY, Kan SF, Chang LS, Wang PS. Role of testicular interstitial macrophages in regulating testosterone release in hyperprolactinemia. J Cell Biochem 88: 766-773, 2003.
25. Jabbour HN, Lincoln GA. Prolactin receptor expression in the testis of the ram: localization, functional activation, and the influence of gonadotrophins. Mol Cell Endocrinol 148: 151-161, 1999.
26. Johnson TE, Vue M, Brekhus S, Khong A, Ho TW, Walker AM. Unmodified prolactin (PRL) promotes PRL secretion and acidophil hypertrophy and is associated with pituitary hyperplasia in female rats. Endocrine 20: 101-109, 2003.
27. Klemcke HG, Bartke A. Effects of chronic hyperprolactinemia in mice on plasma gonadotropin concentrations, and testicular human chorionic gonadotropin binding sites. Endocrinology 108: 1763-1768, 1981.
28. Krown KA, Wang YF, Ho TW, Kelly PA, Walker AM. Prolactin isoform 2 as an autocrine growth factor for GH3 cells. Endocrinology 131: 595-602, 1992.
29. Kuo CB, Wu W, Xu X, Yang L, Chen C, Coss D, Birdsall B, Nasseri D, Walker AM. Pseudophosphorylated prolactin (S179DPRL) inhibits growth, and promotes β-casein gene expression in the rat mammary gland. Cell Tissue Res 309: 429-437, 2002.
30. Leff MA, Buckley DJ, Krumenacker JS, Reed JC, Miyashita T, Buckley AR. Rapid modulation of the apoptosis regulatory genes, bcl-2, and bax by prolactin in rat Nb2 lymphoma cells. Endocrinology 137: 5456-5462, 1996.
31. Lorenson MY, Walker AM. Structure function relationships in prolactin. In: Prolactin, edited by Horseman, ND. Norwell, MA: Kluwer Academic, 2000, p. 188-217.
32. Manna PR, El-Hefnawy T, Kero J, Huhtaniemi IT. Biphasic action of prolactin in the regulation of murine Leydig tumor cell functions. Endocrinology 142: 308-318, 2001.
33. Maran RRM, Arunakaran J, Aruldhas MM. Prolactin, and Leydig cells: biphasic effects of prolactin on LH-, T3-, and GH-induced testosterone/ oestradiol secretion by Leydig cells in pubertal rats. Int J Androl 24: 48-55, 2001.
34. McNeilly AS, Sharpe RM, Fraser HM. Increased sensitivity to the negative feedback effects of testosterone induced by hyperprolactinemia in the adult male rat. Endocrinology 112: 22-28, 1983.
35. Nagano M, Kelly PA. Tissue distribution, and regulation of rat prolactin receptor gene expression. Quantitative analysis by polymerase chain reaction. J Biol Chem 269: 13337-13345, 1994.
36. Purvis K, Clausen OPF, Olsen A, Hang F, Hansson V. Prolactin and Leydig cell responsiveness to LH/hCG. Arch Androl 3: 219-230, 1979.
37. Saidi K, Wenn RV, Sharif F. Bromocriptine for male infertility. Lancet 29: 250-251, 1977.
38. Schroeder MD, Brockman JL, Walker AM, Schuler LA. Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D PRL. Endocrinology 144: 5399-5407, 2003.
39. Taylor MF, de Boer-Brouwer M, Woolveridge I, Teerds KJ, Morris ID. Leydig cell apoptosis after the administration of ethane dimethansulfonate to the adult male rat is a Fas-mediated process. Endocrinology 140: 3797-3804, 1999.
40. Ueda EK, Lo HL, Bartolini P, Walker AMS179D. Prolactin uses the extrinsic pathway, and mitogen-activated protein kinase signaling to induce apoptosis in human endothelial cells. Endocrinology 147: 4627-4637, 2006.
41. Ueda E, Ozerdem U, Chen YH, Yao M, Huang KT, Sun H, Martins-Green M, Bartolini P, Walker AM. A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone. Endo Relat Cancer 13: 95-111, 2006.
42. Waeber C, Reymond O, Reymond M, Lemarchand-Beraud T. Effects of hyper-, and hypoprolactinemia on gonadotropin secretion, rat testicular luteinizing hormone/human chorionic gonadotropin receptors and testosterone production by isolated Leydig cells. Biol Reprod 28: 167-177, 1983.
43. Walker AM. S179D prolactin: antagonistic agony! Mol Cell Endocrinol 276: 1-9, 2007.
44. Wang YF, Walker AM. Dephosphorylation of standard prolactin produces a more biologically active molecule. Evidence for antagonism between non-phosphorylated and phosphorylated prolactin in the stimulation of Nb2 cell proliferation. Endocrinology 133: 2156-2160, 1993.
45. Weiss-Messer E, Ber R, Barkey RJ. Prolactin MA10 Leydig cell steroidogenesis: biphasic effects of prolactin and signal transduction. Endocrinology 137: 5509-5518, 1996.
46. Witorsch RJ, Day EB, Lavoie HA, Hashemi N, Taylor JK. Comparison of glucocorticoid-induced effects in prolactin-dependent, and autonomous rat Nb2 lymphoma cells. Proc Soc Exp Biol Med 203: 454-460, 1993.
47. Wu W, Coss D, Lorenson MY, Kuo CB, Xu X, Walker AM. Different biological effects of unmodified prolactin, and a molecular mimic of phosphorylated prolactin involve different signaling pathways. Biochemistry 42: 7561-7570, 2003.
48. Wu W, Ginsburg E, Vonderhaar BK, Walker AM. S179D prolactin increases vitamin D receptor, and p21 through upregulation of short 1b prolactin receptor in human prostate cancer cells. Cancer Res 65: 7509-7515, 2005.
49. Wu W, Chen YH, Ueda E, Tan D, Bartolini P, Walker AM. Different forms of prolactin have opposing effects on the expression of cell cycle regulatory proteins in differentiated mammary epithelial cells. Oncol Res 16: 75-84, 2006.
50. Xu X, Kreye E, Kuo CB, Walker AM. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence, and size when D.U145 human prostate cancer cells were grown in nude mice. Cancer Res 61: 6098-6104, 2001.
51. Xu X, Wu W, Williams V, Khong A, Chen YH, Deng C, Walker AM. Opposite effects of unmodified prolactin, and a molecular mimic of phosphorylated prolactin on morphology and the expression of prostate specific genes in the normal rat prostate. Prostate 54: 25-33, 2003.
52. Yang L, Kuo CB, Liu Y, Coss D, Xu X, Chen C, Oster-Granite ML, Walker AM. Administration of unmodified prolactin (U-PRL) and molecular mimic of phosphorylated prolactin (PP-PRL) during rat pregnancy provides evidence that the U-PRL:PP-PRL ratio is crucial to the normal development of pup tissues. J Endocrinol 168: 227-238, 2001.
53. Yang L, Lii S, Kuo B, Buckley A, Buckley D, Chen C, Xu X, Coss D, Walker AM. Maternal prolactin composition can permanently affect epidermal T cell function in the offspring. Dev Comp Immunol 26: 849-860, 2002.
54. Zipf WB, Payne AH, Kelch RP. Prolactin, growth hormone, and luteinizing hormone in the maintenance of testicular luteinizing receptors. Endocrinology 103: 595-600, 1978.